Original Research
Published on 19 Feb 2025
The protective role of vitamin D in BNT162b2 vaccine-related acute myocarditis
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1501609
- 6,824 views
Type at least 3 characters
2,890 articles
Mini Review
Published on 18 Feb 2025
Harnessing adjuvant-induced epigenetic modulation for enhanced immunity in vaccines and cancer therapy
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1547213
- 1,010 views
Original Research
Published on 18 Feb 2025
Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1503954
- 1,624 views
- 1 citation
Brief Research Report
Published on 17 Feb 2025
XBB.1.5 mRNA COVID-19 vaccine protection against inpatient or emergency department visits among adults infected with SARS-CoV-2 JN.1 and XBB-lineage variants
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1470609
- 1,099 views
- 1 citation
Original Research
Published on 17 Feb 2025
Intradermal delivery of SARS-CoV-2 RBD3-Fc mRNA vaccines via a needle-free injection system induces robust immune responses in rats
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1530736
- 1,150 views
Original Research
Published on 14 Feb 2025
Report on adverse events of COVID-19 vaccines in Iran: a comprehensive national prospective longitudinal analysis
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1504973
- 1,220 views
Original Research
Published on 13 Feb 2025
Designing a potent multivalent epitope vaccine candidate against Orientia tsutsugamushi via reverse vaccinology technique - bioinformatics and immunoinformatic approach
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1513245
- 1,017 views
Original Research
Published on 13 Feb 2025
Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1540359
- 2,630 views
Original Research
Published on 13 Feb 2025
A single point mutation on FLT3L-Fc protein increases the risk of immunogenicity
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1519452
- 1,202 views
Original Research
Published on 12 Feb 2025
A nucleoside-modified mRNA vaccine prevents enterovirus A71 infection in mouse model
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1535758
- 1,274 views
Original Research
Published on 07 Feb 2025
Adjuvanted subunit intranasal vaccine reduces SARS-CoV-2 onward transmission in hamsters
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1514845
- 1,356 views
Original Research
Published on 06 Feb 2025
BAFF and APRIL immunotherapy following Bacille Calmette-Guérin vaccination enhances protection against pulmonary tuberculosis in mice
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1551183
- 1,264 views
Original Research
Published on 06 Feb 2025
Comparison of air-liquid interface transwell and airway organoid models for human respiratory virus infection studies
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1532144
- 2,494 views
- 1 citation
Correction
Published on 05 Feb 2025
Corrigendum: Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1565688
- 559 views
Original Research
Published on 04 Feb 2025
Discovery and in vitro characterization of a human anti-CD36 scFv
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1531171
- 1,667 views
Original Research
Published on 03 Feb 2025
Evaluation of mucosal adjuvants to chitosan-nanoparticle-based oral subunit vaccine for controlling salmonellosis in broilers
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2025.1509990
- 1,143 views